Current space

Members

Filtered creator directory for "nordisk".

Directory 201.5K Indexed posts 43M Verified 0
Active AuthorsRecent indexed creators Registered MembersAccount directory Completed ProfilesProfiles with public details VerifiedTrusted member signals
201.5KActive members
43MIndexed posts
286KDetailed profiles
4Sources in this view

Active authors

Showing directory results matching your search with real activity counts for visible profiles.

Page 1 | 4 shown
N
Novo Nordisk and Evotec collaborate to launch LAB eN², a translational drug discovery accelerator, to address innovation gap in cardiometabolic diseases
Novo Nordisk to lower U.S. prices of several pre-filled insulin pens and vials up to 75% for people living with diabetes in January 2024
Novo Nordisk announces FDA approval of label update for Rybelsus® (semaglutide) allowing u...
Novo Nordisk avatar
@Novo Nordisk
Novo Nordisk
Feb 8, 2026
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers 10Posts 1Sources 0Reputation
Latest signal 0 reactions
Novo Nordisk announces FDA approval of label update for Rybelsus® (semaglutide) allowing use as a first-line option...
prnewswire.com
0Following 0Comments 0Views 0Shares
N
Novo Nordisk A/S: China’s Supreme People’s Court delivers a
Novo Nordisk A/S: Wegovy® pill approved in the US as first
Aspect Biosystems and Novo Nordisk enter new phase of
Novo Nordisk A/S: China’s Supreme People’s Court delivers a
Novo Nordisk A/S avatar
@Novo Nordisk A/S
Novo Nordisk
Jan 29, 2026
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers 5Posts 1Sources 0Reputation
Latest signal 0 reactions
Novo Nordisk A/S: China’s Supreme People’s Court delivers a
globenewswire.com
0Following 0Comments 0Views 0Shares
N
Novo Nordisk announces significant reduction in US list price for Wegovy®, Ozempic®, and Rybelsus® (semaglutide medicines), building on continued efforts to expand access
Novo Nordisk's Wegovy® pill, the first and only oral GLP-1 for weight loss in adults, now broadly available across America
FDA accepts filing application for oral semaglutide 25 mg, which if approved, would be the first oral GLP-1 treatment for obesity
Novo Nordisk announces significant reduction in US list price for Wegovy®, Ozempic®, and...
NOVO NORDISK INC. avatar
@NOVO NORDISK INC.
NOVO NORDISK
Mar 1, 2026
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers 4Posts 1Sources 0Reputation
Latest signal 0 reactions
Novo Nordisk announces significant reduction in US list price for Wegovy®, Ozempic®, and Rybelsus® (semaglutide me...
prnewswire.com
0Following 0Comments 0Views 0Shares
N
Novo Nordisk's new insulin affordability offerings now available in the US
Novo Nordisk's new insulin affordability offerings now available in the US
Novo Nordisk Inc. and Novo Nordisk Pharma, Inc. avatar
@Novo Nordisk Inc. and Novo Nordisk Pharma, Inc.
Novo Nordisk
Jan 29, 2026
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers 1Posts 1Sources 0Reputation
Latest signal 0 reactions
Novo Nordisk's new insulin affordability offerings now available in the US
prnewswire.com
0Following 0Comments 0Views 0Shares